文献速递产科母胎医学

孕早期原发性巨细胞病毒普遍筛查与伐昔洛韦治疗的成本效果分析

Universal screening and valacyclovir for first trimester primary cytomegalovirus: a cost-effectiveness analysis.
PubMed 文献 · Am J Obstet Gynecol · 2025-02-11

本研究构建决策分析模型,比较孕早期普遍筛查巨细胞病毒并对阳性者给予伐昔洛韦治疗与不筛查的成本效果。

要点

  • 孕早期普遍筛查巨细胞病毒并治疗阳性者,可减少垂直传播及不良结局。
  • 敏感性分析显示筛查策略在100%的蒙特卡洛模拟中保持成本节省。

核心结论

  • 孕早期原发性巨细胞病毒筛查可能是一种节省成本的干预措施,因为识别病例后允许提供治疗,从而减少垂直传播和代价高昂的后遗症。

研究设计与样本

  • 构建决策分析模型,比较普遍筛查及后续伐昔洛韦治疗在2,869,141例理论队列(美国孕早期接受产前保健的孕妇估计数)中的结局。
  • 免疫球蛋白G阳性、免疫球蛋白M阳性且免疫球蛋白G亲和力低的个体被视为原发性巨细胞病毒感染并接受伐昔洛韦。
  • 模型输入来自文献,敏感性分析采用龙卷风分析、单变量敏感性分析和蒙特卡洛模拟的多变量敏感性分析。

主要发现

  • 普遍筛查和后续治疗预防了2898例垂直传播、94例流产、19例死胎、11例新生儿死亡、460例听力损失和263例神经发育障碍。
  • 龙卷风分析显示,当所有变量在预定范围内变动时,没有阈值会改变模型结果。
  • 单变量敏感性分析显示,即使筛查试验特异性降低、新生儿听力损失的母体效用降低、筛查价格增至当前成本的17倍,普遍筛查仍为成本效果策略。
  • 蒙特卡洛分析显示,筛查策略在100%的试验中保持成本节省。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Universal prenatal screening for cytomegalovirus is not currently recommended in the United States, as no effective interventions have previously been available. With growing evidence that treating maternal first trimester primary cytomegalovirus infections with valacyclovir reduces vertical transmission, universal screening may become an important tool in congenital cytomegalovirus prevention. OBJECTIVE: This study examined the cost-effectiveness of a universal screening approach for maternal cytomegalovirus in the first trimester of pregnancy followed by valacyclovir treatment in positive cases for prevention of the sequelae of congenital cytomegalovirus. STUDY DESIGN: A decision-analytic model was constructed to compare outcomes of universal screening and subsequent valacyclovir treatment in a theoretical cohort of 2,869,141 individuals, the estimated number of pregnant people in the United States who receive prenatal care by the first trimester. Individuals found to be immunoglobulin G positive, immunoglobulin M positive, and to have low immunoglobulin G avidity were considered to have primary cytomegalovirus infection and received valacyclovir. Outcomes included cases of vertical cytomegalovirus transmission, abortions, stillbirths, neonatal deaths, cases of hearing loss, cases of neurodevelopmental disabilities, costs, and quality-adjusted life years. Model inputs were derived from literature. Sensitivity analyses were performed via tornado analysis, univariable sensitivity analysis, and multivariable sensitivity analysis with Monte Carlo simulation. RESULTS: In our study, universal screening in the first trimester for primary cytomegalovirus and subsequent treatment with valacyclovir in positive cases decreased adverse outcomes by preventing 2898 vertical transmissions, 94 abortions, 19 stillbirths, 11 neonatal deaths, 460 cases of hearing loss, and 263 cases of neurodevelopmental disability. Universal screening and subsequent treatment was the dominant strategy as it saved 242.2 million dollars and led to 3437 additional quality-adjusted life years. Tornado analysis demonstrated that there were no threshold values which would change the model results, when all variables were varied across a predetermined range. Univariable sensitivity analyses demonstrated that even with decreasing specificity of screening tests, decreasing maternal utility of neonatal hearing loss, and increasing the price of screening up to 17 times the current cost, universal screening remained the cost-effective strategy. Monte Carlo analysis demonstrated that the screening strategy remained cost-saving in 100% of trials. CONCLUSION: Our results demonstrate that screening for first trimester primary cytomegalovirus may be a cost-saving intervention, as identification of cases allows for the provision of treatment, which in turn reduces vertical cytomegalovirus transmission and costly sequelae.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dzubay SK, Gagliuso AH, Arora M, et al. Universal screening and valacyclovir for first trimester primary cytomegalovirus: a cost-effectiveness analysis. Am J Obstet Gynecol. 2025. PMID: 39947573. doi:10.1016/j.ajog.2025.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。